FDA Inspection 1018497 — Vitalant
The FDA completed an inspection of Vitalant on Jul 19, 2017 in Tupelo, MS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tupelo, MS (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12435 | 21 CFR 1271.270(a) | Records maintained concurrently |